Clinical Trials Browser

Phase 2 × CRC × pembrolizumab × Clear all

NCT07511972 2026-04-06

Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Phase 2 Withdrawn

CRC